Immunovant Expects Top-Line Data for Two Clinical Trials of Batoclimab in Thyroid Eye Disease in 1H 2025 >IMVT
Immunovant Expects Top-Line Data for Two Clinical Trials of Batoclimab in Thyroid Eye Disease in 1H 2025 >IMVT
免疫公司預計2025年上半年巴妥布治療甲狀腺眼病的兩項臨牀試驗的一線數據>IMVT
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊